Factors associated with lifetime risk of open-angle glaucoma blindness

Acta Ophthalmologica

Volumn 92, Issue 5, 2014, Pages 421-425

  Peters, Dorothea ^a   Bengtsson, Boel ^a   Heijl, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

age; blindness; disease stage; intraocular pressure; open angle glaucoma; risk factors

Indexed keywords

ADULT; AGED; ARTICLE; BLINDNESS; DEATH; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PSEUDOEXFOLIATION; PSEUDOEXFOLIATIVE GLAUCOMA; RETROSPECTIVE STUDY; RISK FACTOR; STAGING; SWEDEN; VERY ELDERLY; WORLD HEALTH ORGANIZATION; CLASSIFICATION; EXFOLIATION SYNDROME; GLAUCOMA, OPEN-ANGLE; VISUAL ACUITY; VISUAL FIELD;

AGED; AGED, 80 AND OVER; BLINDNESS; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; VISUAL ACUITY; VISUAL FIELDS;

EID: 84904719299     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12203     Document Type: Article

References (17)

1. Ang GS, &, Eke T, (2007): Lifetime visual prognosis for patients with primary open-angle glaucoma. Eye (Lond) 21: 604-608. (Pubitemid 46730708)
2. Bengtsson B, &, Heijl A, (2005): A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma 14: 135-138. (Pubitemid 40389182)
3. Chen PP, (2003): Blindness in patients with treated open-angle glaucoma. Ophthalmology 110: 726-733. (Pubitemid 36520071)
4. Forsman E, Kivela T, &, Vesti E, (2007): Lifetime visual disability in open-angle glaucoma and ocular hypertension. J Glaucoma 16: 313-319. (Pubitemid 46626058)
5. Goh YW, Ang GS, &, Azuara-Blanco A, (2011): Lifetime visual prognosis of patients with glaucoma. Clin Experiment Ophthalmol 39: 766-770.
6. Grant WM, &, Burke JF Jr, (1982): Why do some people go blind from glaucoma? Ophthalmology 89: 991-998. (Pubitemid 12001626)
7. Heijl A, Drance SM, &, Douglas GR, (1980): Automatic perimetry (COMPETER). Ability to detect early glaucomatous field defects. Arch Ophthalmol 98: 1560-1563. (Pubitemid 10001097)
8. Heijl A, Aspberg J, &, Bengtsson B, (2011): The effect of different criteria on the number of patients blind from open-angle glaucoma. BMC Ophthalmol 11: 31.
9. Kooner KS, Albdoor M, Cho BJ, &, Adams-Huet B, (2008): Risk factors for progression to blindness in high tension primary open angle glaucoma: comparison of blind and nonblind subjects. Clin Ophthalmol 2: 757-762.
10. Kwon YH, Kim CS, Zimmerman MB, Alward WL, &, Hayreh SS, (2001): Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol 132: 47-56. (Pubitemid 32600889)
11. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, &, Komaroff E, (2003): Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121: 48-56. (Pubitemid 36401765)
12. Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, Evans SJ, &, Doyle JJ, (2006): Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol 141: 24-30. (Pubitemid 43019202)
13. Oliver JE, Hattenhauer MG, Herman D, Hodge DO, Kennedy R, Fang-Yen M, &, Johnson DH, (2002): Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 133: 764-772. (Pubitemid 34580623)
14. Quigley HA, (1999): Proportion of those with open-angle glaucoma who become blind. Ophthalmology 106: 2039-2041. (Pubitemid 30194218)
15. Singh K, &, Shrivastava A, (2009): Intraocular pressure fluctuations: how much do they matter? Curr Opin Ophthalmol 20: 84-87.
16. Social Security Ruling, SSR 07-01 p; Titles II and XVI: Evaluating Visual Field Loss Using Automated Static Threshold Perimetry. Available at: http://www.ssa.gov/OP-Home/rulings/di/01/SSR2007-01-di-01.html [Accessed May 5, 2011].
17. World Health Organisation (1973): The prevention of blindness. Report of a WHO Study Group. World Health Organ Tech Rep Ser 518: 1-18.